KemPharm Short Interest Ratio and Short Volume

Short interest is the volume of KemPharm shares that have been sold short but have not yet been covered or closed out. As of October 30th, traders have sold 132,000 shares of KMPH short. 0.00% of KemPharm's shares are currently sold short. View details.

KemPharm saw a increase in short interest in the month of October. As of October 30th, there was short interest totaling 132,000 shares, an increase of 160.4% from the previous total of 50,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of KemPharm's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to KemPharm: RedHill Biopharma Ltd. (0.00%), BeyondSpring Inc. (6.29%), Fulcrum Therapeutics, Inc. (9.71%), Altimmune, Inc. (0.00%), Arbutus Biopharma Co. (0.00%), Osmotica Pharmaceuticals plc (7.99%), Kamada Ltd. (1.91%), Verastem, Inc. (0.00%), Summit Therapeutics Inc. (0.24%), and OrganiGram Holdings Inc. (7.60%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.66 billion), Aon Plc ($3.83 billion), Analog Devices, Inc. ($3.33 billion), ViacomCBS Inc. ($3.13 billion), Snap Inc. ($3.05 billion), The Clorox Company ($2.85 billion), Uber Technologies, Inc. ($2.80 billion), Moderna, Inc. ($2.26 billion), Simon Property Group, Inc. ($2.02 billion), and International Flavors & Fragrances Inc. ($1.96 billion). View all of the most shorted stocks.

Short selling KMPH is an investing strategy that aims to generate trading profit from KemPharm as its price is falling. KemPharm's stock is trading down $0.02 today. To short KemPharm stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that KemPharm will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for KemPharm occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KMPH, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KMPH, twice per month. The most recent reporting period available is October, 30 2020.